Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01034 (
cystatin C
)
3,397
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serine incorporator 5
(
SERINC5
) is a recently identified restriction factor that strongly blocks HIV-1 entry but is counteracted by Nef. Notably, tier 1 HIV-1 Env proteins are sensitive to
SERINC5
, whereas the majority of tier 2/3 Env proteins are resistant to
SERINC5
, when viruses are produced from CD4-negative cells and tested by a single-round replication assay. Here, we investigated the Env-dependent
SERINC5
antiviral mechanism by comparing tier 1 NL Env with tier 3
AD8
Env proteins. We found that when NL and
AD8
viruses were inoculated into CD4
+
T cells and human peripheral blood mononuclear cells (PBMCs), the propagation of the two viruses was restricted to a similar level when Nef was not expressed. Using a bimolecular fluorescence complementation (BiFC) assay, we detected Env-Env association and Env-
SERINC5
interactions. A much greater level of NL Env-
SERINC5
interactions was detected than was
AD8
Env-
SERINC5
interactions, which was further validated by immunoprecipitation assays. In addition,
SERINC5
dissociated the NL Env trimeric complex more effectively than the
AD8
Env trimeric complex when CD4 was not expressed. However, when CD4 was expressed,
SERINC5
became more capable of interacting with
AD8
Env and dissociating its trimeric complex. Moreover,
AD8
and several other tier 2/3 viruses produced in the presence of CD4 became sensitive to
SERINC5
when measured by the single-round replication assay. Because tier 1 and tier 2/3 Env trimers have open and closed conformations, respectively, and CD4 opens the closed conformation, we conclude that
SERINC5
selectively dissociates Env trimers with an open conformation to restrict HIV-1 replication.
IMPORTANCE
Restriction factors provide the first line of defense against retrovirus infection by posing several blocks to the viral replication cycle.
SERINC5
is a novel restriction factor that strongly blocks HIV-1 entry, although it is counteracted by Nef. Currently, it is still unclear how HIV-1 entry is blocked by
SERINC5
. Notably, this entry block is dependent on viral Env proteins. Laboratory-adapted HIV-1 strains are sensitive, whereas primary isolates are highly resistant to
SERINC5
. Env proteins mediate virus entry via extensive conformational rearrangements from a closed ground state to a CD4-bound open state. We detected Env-Env associations and Env-
SERINC5
interactions in live cells by a novel bimolecular fluorescence assay. We demonstrate that CD4 expression increases the Env sensitivity to
SERINC5
and allows
SERINC5
to dissociate the Env complex, suggesting that
SERINC5
restriction is dependent on Env conformation. Our results provide new insights into the poorly defined Env-dependent
SERINC5
antiviral mechanism.
...
PMID:CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5. 3104 28